United Therapeutics Operating Income 2006-2020 | UTHR

United Therapeutics operating income from 2006 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
United Therapeutics Annual Operating Income
(Millions of US $)
2019 $-188
2018 $805
2017 $815
2016 $1,062
2015 $699
2014 $539
2013 $292
2012 $422
2011 $318
2010 $171
2009 $26
2008 $-82
2007 $6
2006 $29
2005 $43
United Therapeutics Quarterly Operating Income
(Millions of US $)
2020-06-30 $141
2020-03-31 $167
2019-12-31 $64
2019-09-30 $183
2019-06-30 $221
2019-03-31 $-656
2018-12-31 $132
2018-09-30 $150
2018-06-30 $217
2018-03-31 $307
2017-12-31 $139
2017-09-30 $324
2017-06-30 $89
2017-03-31 $264
2016-12-31 $174
2016-09-30 $239
2016-06-30 $285
2016-03-31 $364
2015-12-31 $155
2015-09-30 $387
2015-06-30 $172
2015-03-31 $-15
2014-12-31 $179
2014-09-30 $-32
2014-06-30 $176
2014-03-31 $216
2013-12-31 $-28
2013-09-30 $105
2013-06-30 $122
2013-03-31 $94
2012-12-31 $129
2012-09-30 $81
2012-06-30 $106
2012-03-31 $107
2011-12-31 $64
2011-09-30 $103
2011-06-30 $114
2011-03-31 $37
2010-12-31 $15
2010-09-30 $62
2010-06-30 $61
2010-03-31 $32
2009-12-31 $-2
2009-09-30 $12
2009-06-30 $-4
2009-03-31 $21
2008-12-31 $-134
2008-09-30 $18
2008-06-30 $19
2008-03-31 $15
2007-12-31 $-8
2007-09-30 $14
2007-06-30 $8
2007-03-31 $-8
2006-12-31 $4
2006-09-30 $11
2006-06-30 $12
2006-03-31 $2
2005-12-31 $10
2005-09-30 $15
2005-06-30 $11
2005-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.983B $1.449B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.622B 43.60
Takeda Pharmaceutical (TAK) Japan $57.348B 9.99
Astellas Pharma (ALPMY) Japan $29.230B 14.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.222B 22.58
Catalent (CTLT) United States $13.660B 52.81
Grifols, S.A (GRFS) Spain $12.713B 15.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.819B 41.88
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.894B 50.01
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $7.047B 11.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.196B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
Hypermarcas (HYPMY) Brazil $4.097B 15.07
Nektar Therapeutics (NKTR) United States $3.829B 0.00
FibroGen (FGEN) United States $3.693B 0.00
ChemoCentryx (CCXI) United States $3.370B 0.00
PTC Therapeutics (PTCT) United States $3.183B 0.00
Sage Therapeutics (SAGE) United States $2.596B 0.00
Pacira BioSciences (PCRX) United States $2.448B 65.32
Taro Pharmaceutical Industries (TARO) Israel $2.420B 11.71
Cronos Group (CRON) Canada $2.054B 0.00
Xencor (XNCR) United States $1.833B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.791B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.35
Corcept Therapeutics (CORT) United States $1.614B 14.86
Ironwood Pharmaceuticals (IRWD) United States $1.608B 11.21
Indivior (INVVY) United States $1.606B 19.93
Revolution Medicines (RVMD) United States $1.513B 0.00
Akebia Therapeutics (AKBA) United States $1.441B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 13.34
Heron Therapeutics (HRTX) United States $1.391B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.315B 0.00
Zogenix (ZGNX) United States $1.311B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Karyopharm Therapeutics (KPTI) United States $1.121B 0.00
Esperion Therapeutics (ESPR) United States $1.065B 0.00
VAXART, INC (VXRT) United States $0.992B 0.00
Tilray (TLRY) Canada $0.969B 0.00
Translate Bio (TBIO) United States $0.957B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.926B 578.88
Altimmune (ALT) United States $0.848B 0.00
Endo (ENDP) Ireland $0.813B 1.20
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.706B 0.00
ImmunoGen (IMGN) United States $0.688B 0.00
Flexion Therapeutics (FLXN) United States $0.634B 0.00
Trillium Therapeutics (TRIL) Canada $0.625B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Aerie Pharmaceuticals (AERI) United States $0.562B 0.00
Radius Health (RDUS) United States $0.539B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Molecular Templates (MTEM) United States $0.509B 0.00
Ardelyx (ARDX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.487B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.34
DURECT (DRRX) United States $0.467B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.455B 0.00
Ocular Therapeutix (OCUL) United States $0.451B 0.00
TherapeuticsMD (TXMD) United States $0.437B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.429B 10.36
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Organogenesis Holdings (ORGO) United States $0.410B 0.00
Calithera Biosciences (CALA) United States $0.353B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.318B 0.00
IMV INC (IMV) Canada $0.313B 0.00
OptiNose (OPTN) United States $0.292B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
PROFOUND MEDICL (PROF) Canada $0.286B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.248B 5.44
CASI Pharmaceuticals (CASI) United States $0.230B 0.00
Aquestive Therapeutics (AQST) United States $0.204B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
Nivalis Therapeutics (ALPN) United States $0.199B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 25.82
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.187B 0.00
Onconova Therapeutics (ONTX) United States $0.180B 0.00
Heat Biologics (HTBX) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.90
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.141B 0.00
Xeris Pharmaceuticals (XERS) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
MediWound (MDWD) Israel $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Otonomy (OTIC) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Biomerica (BMRA) United States $0.104B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.097B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
Hemispherx BioPharma (AIM) United States $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.094B 0.00
Lipocine (LPCN) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Sundial Growers (SNDL) Canada $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.059B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
AgeX Therapeutics (AGE) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
IsoRay (ISR) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.16
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.09
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 35.29
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00